Viral reverse transcriptases

Virus Research

Volumn 234, Issue , 2017, Pages 153-176

  Menéndez Arias, Luis ^a   Sebastián Martín, Alba ^a   Álvarez, Mar ^a  

^a CSIC   (Spain)

Author keywords

Antiviral drugs; DNA polymerase; Fidelity; Hepatitis B virus; HIV; Retrovirus; Reverse transcriptase; Ribonuclease H

Indexed keywords

DNA POLYMERASE; HEPATITIS B VIRUS POLYMERASE; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENZYME;

DNA SYNTHESIS; DOUBLE-STRANDED DNA REVERSE TRANSCRIBING VIRUS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HEPADNAVIRIDAE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; RETROPOSON; RETROVIRIDAE; REVERSE TRANSCRIPTION; REVIEW; VIRUS RECOMBINATION; ANIMAL; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; VIRUS; VIRUS REPLICATION;

ANIMALS; HUMANS; RNA-DIRECTED DNA POLYMERASE; VIRUS REPLICATION; VIRUSES;

EID: 85009932151     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.12.019     Document Type: Review

References (281)

1. Abbink, T.E., Berkhout, B., HIV-1 reverse transcription: close encounters between the viral genome and a cellular tRNA. Adv. Pharmacol. 55 (2007), 99–135.
2. Abraham, T.M., Loeb, D.D., The topology of hepatitis B virus pregenomic RNA promotes its replication. J. Virol. 81 (2007), 11577–11584.
3. Abram, M.E., Parniak, M.A., Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain. J. Virol. 79 (2005), 11952–11961.
4. Álvarez, M., Matamoros, T., Menéndez-Arias, L., Increased thermostability and fidelity of DNA synthesis of wild-type and mutant HIV-1 group O reverse transcriptases. J. Mol. Biol. 392 (2009), 872–884.
5. Álvarez, M., Barrioluengo, V., Afonso-Lehmann, R.N., Menéndez-Arias, L., Altered error specificity of RNase H-deficient HIV-1 reverse transcriptases during DNA-dependent DNA synthesis. Nucleic Acids Res. 41 (2013), 4601–4612.
6. An, W., Telesnitsky, A., Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J. Virol. 76 (2002), 7897–7902.
7. Archer, J., Pinney, J.W., Fan, J., Simon-Loriere, E., Arts, E.J., Negroni, M., Robertson, D.L., Identifying the important HIV-1 recombination breakpoints. PLoS Comput. Biol., 4, 2008, e1000178.
8. Arts, E.J., Hazuda, D.J., HIV-1 antiretroviral drug therapy. Cold Spring Harb. Perspect. Med., 2, 2012, a007161.
9. Arts, E.J., Ghosh, M., Jacques, P.S., Ehresmann, B., Le Grice, S.F., Restoration of tRNA3Lys-primed(−)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs: implications for retroviral replication. J. Biol. Chem. 271 (1996), 9054–9061.
10. Asahchop, E.L., Wainberg, M.A., Oliveira, M., Xu, H., Brenner, B.G., Moisi, D., Ibanescu, I.R., Tremblay, C., Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline. AIDS 27 (2013), 879–887.
11. Atwood-Moore, A., Ejebe, K., Levin, H.L., Specific recognition and cleavage of the plus-strand primer by reverse transcriptase. J. Virol. 79 (2005), 14863–14875.
12. Avila-Rios, S., Sued, O., Rhee, S.Y., Shafer, R.W., Reyes-Teran, G., Ravasi, G., Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS One, 11, 2016, e0158560.
13. Azijn, H., Tirry, I., Vingerhoets, J., de Béthune, M.P., Kraus, G., Boven, K., Jochmans, D., Van Craenenbroeck, E., Picchio, G., Rimsky, L.T., TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1. Antimicrob. Agents Chemother. 54 (2010), 718–727.
14. Baeten, J.M., Palanee-Phillips, T., Brown, E.R., Schwartz, K., Soto-Torres, L.E., Govender, V., Mgodi, N.M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., Siva, S., Bekker, L.G., Jeenarain, N., Gaffoor, Z., Martinson, F., Makanani, B., Pather, A., Naidoo, L., Husnik, M., Richardson, B.A., Parikh, U.M., Mellors, J.W., Marzinke, M.A., Hendrix, C.W., van der Straten, A., Ramjee, G., Chirenje, Z.M., Nakabiito, C., Taha, T.E., Jones, J., Mayo, A., Scheckter, R., Berthiaume, J., Livant, E., Jacobson, C., Ndase, P., White, R., Patterson, K., Germuga, D., Galaska, B., Bunge, K., Singh, D., Szydlo, D.W., Montgomery, E.T., Mensch, B.S., Torjesen, K., Grossman, C.I., Chakhtoura, N., Nel, A., Rosenberg, Z., McGowan, I., Hillier, S., MTN-020-ASPIRE Study Team, Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N. Engl. J. Med. 375 (2016), 2121–2132.
15. Baird, H.A., Galetto, R., Gao, Y., Simon-Loriere, E., Abreha, M., Archer, J., Fan, J., Robertson, D.L., Arts, E.J., Negroni, M., Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res. 34 (2006), 5203–5216.
16. Baltimore, D., RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226 (1970), 1209–1211.
17. Barrioluengo, V., Álvarez, M., Barbieri, D., Menéndez-Arias, L., Thermostable HIV-1 group O reverse transcriptase variants with the same fidelity as murine leukaemia virus reverse transcriptase. Biochem. J. 436 (2011), 599–607.
18. Barrioluengo, V., Wang, Y., Le Grice, S.F., Menéndez-Arias, L., Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase. FEBS J. 279 (2012), 1433–1444.
19. Basu, V.P., Song, M., Gao, L., Rigby, S.T., Hanson, M.N., Bambara, R.A., Strand transfer events during HIV-1 reverse transcription. Virus Res. 134 (2008), 19–38.
20. Baumert, T.F., Rösler, C., Malim, M.H., von Weizsäcker, F., Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46 (2007), 682–689.
21. Beck, J., Nassal, M., Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli. J. Virol. 75 (2001), 7410–7419.
22. Beck, J., Nassal, M., Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J. Biol. Chem. 278 (2003), 36128–36138.
23. Beilhartz, G.L., Götte, M., HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors. Viruses 2 (2010), 900–926.
24. Beilhartz, G.L., Ngure, M., Johns, B.A., DeAnda, F., Gerondelis, P., Götte, M., Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation. J. Biol. Chem. 289 (2014), 16270–16277.
25. Betancor, G., Álvarez, M., Marcelli, B., Andrés, C., Martínez, M.A., Menéndez-Arias, L., Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis. Nucleic Acids Res. 43 (2015), 2259–2270.
26. Bibillo, A., Lener, D., Klarmann, G.J., Le Grice, S.F.J., Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase. Nucleic Acids Res. 33 (2005), 171–181.
27. Bird, L.E., Chamberlain, P.P., Stewart-Jones, G.B., Ren, J., Stuart, D.I., Stammers, D.K., Cloning, expression, purification, and crystallisation of HIV-2 reverse transcriptase. Protein Expr. Purif. 27 (2003), 12–18.
28. Block, T.M., Rawat, S., Brosgart, C.L., Chronic hepatitis B: a wave of new therapies on the horizon. Antiviral Res. 121 (2015), 69–81.
29. Borkow, G., Fletcher, R.S., Barnard, J., Arion, D., Motakis, D., Dmitrienko, G.I., Parniak, M.A., Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone. Biochemistry 36 (1997), 3179–3185.
30. Boyer, P.L., Stenbak, C.R., Hoberman, D., Linial, M.L., Hughes, S.H., In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology 367 (2007), 253–264.
31. Cai, C.W., Lomonosova, E., Moran, E.A., Cheng, X., Patel, K.B., Bailly, F., Cotelle, P., Meyers, M.J., Tavis, J.E., Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity. Antiviral Res. 108 (2014), 48–55.
32. Cases-González, C.E., Gutiérrez-Rivas, M., Menéndez-Arias, L., Coupling ribose selection to fidelity of DNA synthesis: the role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 275 (2000), 19759–19767.
33. Chabannes, M., Iskra-Caruana, M.L., Endogenous pararetroviruses–a reservoir of virus infection in plants. Curr. Opin. Virol. 3 (2013), 615–620.
34. Champoux, J.J., Schultz, S.J., Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription. FEBS J. 276 (2009), 1506–1516.
35. Chapman, K.B., Byström, A.S., Boeke, J.D., Initiator methionine tRNA is essential for Ty1 transposition in yeast. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 3236–3240.
36. Charneau, P., Alizon, M., Clavel, F., A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66 (1992), 2814–2820.
37. Chen, J., Powell, D., Hu, W.S., High frequency of genetic recombination is a common feature of primate lentivirus replication. J. Virol. 80 (2006), 9651–9658.
38. Chung, S., Miller, J.T., Johnson, B.C., Hughes, S.H., Le Grice, S.F., Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J. Biol. Chem. 287 (2012), 4066–4075.
39. Chung, S., Miller, J.T., Lapkouski, M., Tian, L., Yang, W., Le Grice, S.F., Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybrids. J. Biol. Chem. 288 (2013), 16177–16184.
40. Clark, D.N., Hu, J., Hepatitis B virus reverse transcriptase − Target of current antiviral therapy and future drug development. Antiviral Res. 123 (2015), 132–137.
41. Coffin, J.M., Fan, H., The discovery of reverse transcriptase. Annu. Rev. Virol. 3 (2016), 29–51.
42. Cohen, C.J., Andrade-Villanueva, J., Clotet, B., Fourie, J., Johnson, M.A., Ruxrungtham, K., Wu, H., Zorrilla, C., Crauwels, H., Rimsky, L.T., Vanveggel, S., Boven, K., THRIVE Study group, Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet 378 (2011), 229–237.
43. Corona, A., Meleddu, R., Esposito, F., Distinto, S., Bianco, G., Masaoka, T., Maccioni, E., Menéndez-Arias, L., Alcaro, S., Le Grice, S.F.J., Tramontano, E., Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6. PLoS One, 11, 2016, e0147225.
44. Coté, M.L., Roth, M.J., Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase. Virus Res. 134 (2008), 186–202.
45. Cui, X., McAllister, R., Boregowda, R., Sohn, J.A., Cortes Ledesma, F., Caldecott, K.W., Seeger, C., Hu, J., Does tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair?. PLoS One, 10, 2015, e0128401.
46. Curcio, M.J., Lutz, S., Lesage, P., The Ty1 LTR-retrotransposon of budding yeast, Saccharomyces cerevisiae. Microbiol. Spectr. 3 (2015), 1–35 (MDNA3-0053-2014).
47. Darlix, J.L., Godet, J., Ivanyi-Nagy, R., Fossé, P., Mauffret, O., Mély, Y., Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J. Mol. Biol. 410 (2011), 565–581.
48. Das, K., Arnold, E., HIV-1 reverse transcriptase and antiviral drug resistance. Part 1. Curr. Opin. Virol. 3 (2013), 111–118.
49. Das, K., Arnold, E., HIV-1 reverse transcriptase and antiviral drug resistance. Part 2. Curr. Opin. Virol. 3 (2013), 119–128.
50. Das, D., Georgiadis, M.M., The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure 12 (2004), 819–829.
51. Lys,3. J. Virol. 69 (1995), 3090–3097.
52. Das, K., Bandwar, R.P., White, K.L., Feng, J.Y., Sarafianos, S.G., Tuske, S., Tu, X., Clark, A.D. Jr., Boyer, P.L., Hou, X., Gaffney, B.L., Jones, R.A., Miller, M.D., Hughes, S.H., Arnold, E., Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J. Biol. Chem. 284 (2009), 35092–35100.
53. Das, K., Martinez, S.E., Bauman, J.D., Arnold, E., HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat. Struct. Mol. Biol. 19 (2012), 253–259.
54. De Clercq, E., The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS). Adv. Pharmacol. 67 (2013), 317–358.
55. Delviks-Frankenberry, K.A., Nikolenko, G.N., Boyer, P.L., Hughes, S.H., Coffin, J.M., Jere, A., Pathak, V.K., HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 10943–10948.
56. Delviks-Frankenberry, K., Galli, A., Nikolaitchik, O., Mens, H., Pathak, V.K., Hu, W.-S., Mechanisms and factors that influence high frequency retroviral recombination. Viruses 3 (2011), 1650–1680.
57. DeStefano, J.J., Buiser, R.G., Mallaber, L.M., Myers, T.W., Bambara, R.A., Fay, P.J., Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J. Biol. Chem. 266 (1991), 7423–7431.
58. Deval, J., Selmi, B., Boretto, J., Egloff, M.P., Guerreiro, C., Sarfati, S., Canard, B., The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using α-boranophosphate nucleotide analogues. J. Biol. Chem. 277 (2002), 42097–42104.
59. Deval, J., Alvarez, K., Selmi, B., Bermond, M., Boretto, J., Guerreiro, C., Mulard, L., Canard, B., Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α-boranophosphate nucleoside analogs. J. Biol. Chem. 280 (2005), 3838–3846.
60. Dewannieux, M., Heidmann, T., Endogenous retroviruses: acquisition, amplification and taming of genome invaders. Curr. Opin. Virol. 3 (2013), 646–656.
61. Diamond, T.L., Souroullas, G., Weiss, K.K., Lee, K.Y., Bambara, R.A., Dewhurst, S., Kim, B., Mechanistic understanding of an altered fidelity simian immunodeficiency virus reverse transcriptase mutation, V148I, identified in a pig-tailed macaque. J. Biol. Chem. 278 (2003), 29913–29924.
62. Ding, J., Das, K., Hsiou, Y., Sarafianos, S.G., Clark, A.D. Jr., Jacobo-Molina, A., Tantillo, C., Hughes, S.H., Arnold, E., Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J. Mol. Biol. 284 (1998), 1095–1111.
63. Dunn, L.L., McWilliams, M.J., Das, K., Arnold, E., Hughes, S.H., Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions. J. Virol. 83 (2009), 12336–12344.
64. Eckert, K.A., Kunkel, T.A., Fidelity of DNA synthesis catalyzed by human DNA polymerase α and HIV-1 reverse transcriptase: effect of reaction pH. Nucleic Acids Res. 21 (1993), 5212–5220.
65. Eickbush, T.H., Jamburuthugoda, V.K., The diversity of retrotransposons and the properties of their reverse transcriptases. Virus Res. 134 (2008), 221–234.
66. Eickbush, T.H., Malik, H.S., Origins and evolution of retrotransposons. Craig, N.L., Craigie, R., Gellert, M., Lambowitz, A.L., (eds.) Mobile DNA II, 2002, ASM Press, Washington DC, 1111–1144.
67. Elder, J.H., Lerner, D.L., Hasselkus-Light, C.S., Fontenot, D.J., Hunter, E., Luciw, P.A., Montelaro, R.C., Phillips, T.R., Distinct subsets of retroviruses encode dUTPase. J. Virol. 66 (1992), 1791–1794.
68. Entin-Meer, M., Avidan, O., Hizi, A., The mature reverse transcriptase molecules in virions of mouse mammary tumor virus possess protease-derived sequences. Virology 310 (2003), 157–162.
69. Fan, N., Rank, K.B., Leone, J.W., Heinrikson, R.L., Bannow, C.A., Smith, C.W., Evans, D.B., Poppe, S.M., Tarpley, W.G., Rothrock, D.J., Tomasselli, A.G., Sharma, S.K., The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases. J. Biol. Chem. 270 (1995), 13573–13579.
70. Fan, J., Negroni, M., Robertson, D.L., The distribution of HIV-1 recombination breakpoints. Infect. Genet. Evol. 7 (2007), 717–723.
71. Feng, M., Wang, D., Grobler, J.A., Hazuda, D.J., Miller, M.D., Lai, M.T., In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. Antimicrob. Agents Chemother. 59 (2015), 590–598.
72. Fisher, T.S., Darden, T., Prasad, V.R., Substitutions at Phe61 in the β3-β4 hairpin of HIV-1 reverse transcriptase reveal a role for the Fingers subdomain in strand displacement DNA synthesis. J. Mol. Biol. 325 (2003), 443–459.
73. Fujiwara, H., Site-specific non-LTR retrotransposons. Microbiol. Spectr., 3, 2015 MDNA3-0001-2014.
74. Gao, G., Orlova, M., Georgiadis, M.M., Hendrickson, W.A., Goff, S.P., Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 407–411.
75. Garforth, S.J., Domaoal, R.A., Lwatula, C., Landau, M.J., Meyer, A.J., Anderson, K.S., Prasad, V.R., K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies. J. Mol. Biol. 401 (2010), 33–44.
76. Golinelli, M.P., Hughes, S.H., Nontemplated base addition by HIV-1 RT can induce nonspecific strand transfer in vitro. Virology 294 (2002), 122–134.
77. Golinelli, M.P., Hughes, S.H., Nontemplated nucleotide addition by HIV-1 reverse transcriptase. Biochemistry 41 (2002), 5894–5906.
78. Gong, Q., Menon, L., Ilina, T., Miller, L.G., Ahn, J., Parniak, M.A., Ishima, R., Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor. Chem. Biol. Drug Des. 77 (2011), 39–47.
79. Gout, J.F., Thomas, W.K., Smith, Z., Okamoto, K., Lynch, M., Large-scale detection of in vivo transcription errors. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 18584–18589.
80. Haas, M., Bureau, M., Geldreich, A., Yot, P., Keller, M., Cauliflower mosaic virus: still in the news. Mol. Plant Pathol. 3 (2002), 419–429.
81. Harris, R.S., Hultquist, J.F., Evans, D.T., The restriction factors of human immunodeficiency virus. J. Biol. Chem. 287 (2012), 40875–40883.
82. Hartl, M.J., Wöhrl, B.M., Rösch, P., Schweimer, K., The solution structure of the simian foamy virus protease reveals a monomeric protein. J. Mol. Biol. 381 (2008), 141–149.
83. Hartl, M.J., Bodem, J., Jochheim, F., Rethwilm, A., Rösch, P., Wöhrl, B.M., Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses. J. Virol. 85 (2011), 4462–4469.
84. Hatfield, D., Oroszlan, S., The where, what and how of ribosomal frameshifting in retroviral protein synthesis. Trends Biochem. Sci. 15 (1990), 186–190.
85. Havecker, E.R., Gao, X., Voytas, D.F., The diversity of LTR retrotransposons. Genome Biol., 5, 2004, 225.
86. Hemelaar, J., Gouws, E., Ghys, P.D., Osmanov, S., WHO-UNAIDS Network for HIV Isolation and Characterisation, Global trends in molecular epidemiology of HIV-1 during 2000–2007. AIDS 25 (2011), 679–689.
87. Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.C., Marquet, R., Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol. Mol. Biol. Rev. 73 (2009), 211–232.
88. Herschhorn, A., Hizi, A., Retroviral reverse transcriptases. Cell. Mol. Life Sci. 67 (2010), 2717–2747.
89. Hilditch, L., Towers, G.J., A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr. Opin. Virol. 4 (2014), 32–36.
90. Himmel, D.M., Sarafianos, S.G., Dharmasena, S., Hossain, M.M., McCoy-Simandle, K., Ilina, T., Clark, A.D. Jr., Knight, J.L., Julias, J.G., Clark, P.K., Krogh-Jespersen, K., Levy, R.M., Hughes, S.H., Parniak, M.A., Arnold, E., HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. ACS Chem. Biol. 1 (2006), 702–712.
91. Hirsch, R.C., Lavine, J.E., Chang, L.J., Varmus, H.E., Ganem, D., Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344 (1990), 552–555.
92. Hizi, A., Herschhorn, A., Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): a comparison of their molecular and biochemical properties. Virus Res. 134 (2008), 203–220.
93. Hizi, A., Herzig, E., dUTPase: the frequently overlooked enzyme encoded by many retroviruses. Retrovirology 12, 70, 2015 Erratum in: Retrovirology 12, 2015, 77.
94. Hizi, A., Joklik, W.K., RNA-dependent DNA polymerase of avian sarcoma virus B77 I. Isolation and partial characterization of the α, β2, and αβ forms of the enzyme. J. Biol. Chem. 252 (1977), 2281–2289.
95. Hohn, T., Rothnie, H., Plant pararetroviruses: replication and expression. Curr. Opin. Virol. 3 (2013), 621–628.
96. Hu, J., Anselmo, D., In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J. Virol. 74 (2000), 11447–11455.
97. Hu, J., Seeger, C., Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 1060–1064.
98. Hu, J., Seeger, C., Hepadnavirus genome replication and persistence. Cold Spring Harb. Perspect. Med., 5, 2015, a021386.
99. Hu, W.S., Temin, H.M., Retroviral recombination and reverse transcription. Science 250 (1990), 1227–1233.
100. Hu, W.S., Temin, H.M., Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 1556–1560.
101. Hu, J., Toft, D.O., Seeger, C., Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16 (1997), 59–68.
102. Hu, J., Toft, D., Anselmo, D., Wang, X., In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J. Virol. 76 (2002), 269–279.
103. Hu, J., Flores, D., Toft, D., Wang, X., Nguyen, D., Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 78 (2004), 13122–13131.
104. Hu, Y., Cheng, X., Cao, F., Huang, A., Tavis, J.E., β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity. Antiviral Res. 99 (2013), 221–229.
105. Huang, H., Chopra, R., Verdine, G.L., Harrison, S.C., Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282 (1998), 1669–1675.
106. Huber, H.E., McCoy, J.M., Seehra, J.S., Richardson, C.C., Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J. Biol. Chem. 264 (1989), 4669–4678.
107. Hughes, S.H., Reverse transcription of retroviruses and LTR retrotransposons. Microbiol. Spectr., 3, 2015 MDNA3-0027-2014.
108. Hull, R., Molecular biology of rice tungro viruses. Annu. Rev. Phytopathol. 34 (1996), 275–297.
109. Hungnes, O., Tjotta, E., Grinde, B., Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 190 (1992), 440–442.
110. Hütter, S., Müllers, E., Stanke, N., Reh, J., Lindemann, D., Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. J. Virol. 87 (2013), 3163–3176.
111. Ilina, T., Labarge, K., Sarafianos, S.G., Ishima, R., Parniak, M.A., Inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H activity. Biology (Basel) 1 (2012), 521–541.
112. Inouye, S., Herzer, P.J., Inouye, M., Two independent retrons with highly diverse reverse transcriptases in Myxococcus xanthus. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 942–945.
113. Isel, C., Lanchy, J.M., Le Grice, S.F., Ehresmann, C., Ehresmann, B., Marquet, R., Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. EMBO J. 15 (1996), 917–924.
114. Jacks, T., Townsley, K., Varmus, H.E., Majors, J., Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 4298–4302.
115. Jackson, D.L., Lee, E.G., Linial, M.L., Expression of prototype foamy virus pol as a Gag-Pol fusion protein does not change the timing of reverse transcription. J. Virol. 87 (2013), 1252–1254.
116. Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark, A.D. Jr., Lu, X., Tantillo, C., Williams, R.L., Kamer, G., Ferris, A.L., Clark, P., Hizi, A., Hughes, S.H., Arnold, E., Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 6320–6324.
117. Janahi, E.M., McGarvey, M.J., The inhibition of hepatitis B virus by APOBEC cytidine deaminases. J. Viral Hepat. 20 (2013), 821–828.
118. Javanbakht, H., Ptak, R.G., Chow, E., Yan, J.M., Russell, J.D., Mankowski, M.K., Hogan, P.A., Hogg, J.H., Vora, H., Hang, J.Q., Li, Y., Su, G., Paul, A., Cammack, N., Klumpp, K., Heilek, G., In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor. Antiviral Res. 86 (2010), 212–219.
119. Jeong, J.K., Yoon, G.S., Ryu, W.S., Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA. J. Virol. 74 (2000), 5502–5508.
120. Johns, B.A., Velthuisen, E.J., 2011. Therapeutic compounds. WO2011075747 (A1). Patent.
121. Jones, S.A., Hu, J., Protein-primed terminal transferase activity of hepatitis B virus polymerase. J. Virol. 87 (2013), 2563–2576 Erratum in: J. Virol. 87, 2013, 12505.
122. Jones, S.A., Boregowda, R., Spratt, T.E., Hu, J., In vitro ε RNA-dependent protein priming activity of human hepatitis B virus polymerase. J. Virol. 86 (2012), 5134–5150 Erratum in: J. Virol. 87, 2013, 12504.
123. Jones, S.A., Murakami, E., Delaney, W., Furman, P., Hu, J., Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine. Antimicrob. Agents Chemother. 57 (2013), 4181–4189 Erratum in: Antimicrob. Agents Chemother. 57, 2013, 5788.
124. Jones, S.A., Clark, D.N., Cao, F., Tavis, J.E., Hu, J., Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming. J. Virol. 88 (2014), 1564–1572.
125. Kati, W.M., Johnson, K.A., Jerva, L.F., Anderson, K.S., Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267 (1992), 25988–25997.
126. Kawamoto, A., Kodama, E., Sarafianos, S.G., Sakagami, Y., Kohgo, S., Kitano, K., Ashida, N., Iwai, Y., Hayakawa, H., Nakata, H., Mitsuya, H., Arnold, E., Matsuoka, M., 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. Int. J. Biochem. Cell Biol. 40 (2008), 2410–2420.
127. Ke, N., Gao, X., Keeney, J.B., Boeke, J.D., Voytas, D.F., The yeast retrotransposon Ty5 uses the anticodon stem-loop of the initiator methionine tRNA as a primer for reverse transcription. RNA 5 (1999), 929–938.
128. Keeney, J.B., Chapman, K.B., Lauermann, V., Voytas, D.F., Aström, S.U., von Pawel-Rammingen, U., Byström, A., Boeke, J.D., Multiple molecular determinants for retrotransposition in a primer tRNA. Mol. Cell. Biol. 15 (1995), 217–226.
129. Kerr, S.G., Anderson, K.S., RNA dependent DNA replication fidelity of HIV-1 reverse transcriptase: evidence of discrimination between DNA and RNA substrates. Biochemistry 36 (1997), 14056–14063.
130. Kim, J., Roberts, A., Yuan, H., Xiong, Y., Anderson, K.S., Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase. J. Mol. Biol. 415 (2012), 866–880.
131. Kim, E.Y., Lorenzo-Redondo, R., Little, S.J., Chung, Y.S., Phalora, P.K., Maljkovic Berry, I., Archer, J., Penugonda, S., Fischer, W., Richman, D.D., Bhattacharya, T., Malim, M.H., Wolinsky, S.M., Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog., 10, 2014, e1004281.
132. King, A.M.Q., Adams, M.J., Carstens, E.B., Lefkowitz, E.J., (eds.) Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses, 2012, Elsevier, San Diego (1338 pp).
133. Kirschberg, T.A., Balakrishnan, M., Squires, N.H., Barnes, T., Brendza, K.M., Chen, X., Eisenberg, E.J., Jin, W., Kutty, N., Leavitt, S., Liclican, A., Liu, Q., Liu, X., Mak, J., Perry, J.K., Wang, M., Watkins, W.J., Lansdon, E.B., RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. J. Med. Chem. 52 (2009), 5781–5784.
134. Kirshenboim, N., Hayouka, Z., Friedler, A., Hizi, A., Expression and characterization of a novel reverse transcriptase of the LTR retrotransposon Tf1. Virology 366 (2007), 263–276.
135. Kisic, M., Matamoros, T., Nevot, M., Mendieta, J., Martinez-Picado, J., Martínez, M.A., Menéndez-Arias, L., Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase. J. Biol. Chem. 286 (2011), 20615–20624.
136. Ko, C., Shin, Y.C., Park, W.J., Kim, S., Kim, J., Ryu, W.S., Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis. J. Virol. 88 (2014), 154–163.
137. Königer, C., Wingert, I., Marsmann, M., Rösler, C., Beck, J., Nassal, M., Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4244–E4253.
138. Köppe, B., Menéndez-Arias, L., Oroszlan, S., Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. J. Virol. 68 (1994), 2313–2319.
139. Křízová, I., Hadravová, R., Štokrová, J., Günterová, J., Doležal, M., Ruml, T., Rumlová, M., Pichová, I., The G-patch domain of Mason-Pfizer monkey virus is a part of reverse transcriptase. J. Virol. 86 (2012), 1988–1998.
140. Kunkel, T.A., DNA replication fidelity. J. Biol. Chem. 279 (2004), 16895–16898.
141. Kurzynska-Kokorniak, A., Jamburuthugoda, V.K., Bibillo, A., Eickbush, T.H., DNA-directed DNA polymerase and strand displacement activity of the reverse transcriptase encoded by the R2 retrotransposon. J. Mol. Biol. 374 (2007), 322–333.
142. Lambowitz, A.M., Zimmerly, S., Mobile group II introns. Annu. Rev. Genet. 38 (2004), 1–35.
143. Lampson, B.C., Inouye, M., Inouye, S., Retrons, msDNA, and the bacterial genome. Cytogenet. Genome Res. 110 (2005), 491–499.
144. Lanford, R.E., Notvall, L., Beames, B., Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J. Virol. 69 (1995), 4431–4439.
145. Lanford, R.E., Notvall, L., Lee, H., Beames, B., Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71 (1997), 2996–3004.
146. Lapkouski, M., Tian, L., Miller, J.T., Le Grice, S.F., Yang, W., Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation. Nat. Struct. Mol. Biol. 20 (2013), 230–236.
147. Lau, K.A., Wong, J.J., Current trends of HIV recombination worldwide. Infect. Dis. Rep., 5(Suppl. 1), 2013, e4.
148. Le Grice, S.F., Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J. Biol. Chem. 287 (2012), 40850–40857.
149. Leblanc, P., Desset, S., Giorgi, F., Taddei, A.R., Fausto, A.M., Mazzini, M., Dastugue, B., Vaury, C., Life cycle of an endogenous retrovirus, ZAM, in Drosophila melanogaster. J. Virol. 74 (2000), 10658–10669.
150. Lee, E.G., Stenbak, C.R., Linial, M.L., Foamy virus assembly with emphasis on pol encapsidation. Viruses 5 (2013), 886–900.
151. Lener, D., Budihas, S.R., Le Grice, S.F., Mutating conserved residues in the ribonuclease H domain of Ty3 reverse transcriptase affects specialized cleavage events. J. Biol. Chem. 277 (2002), 26486–26495.
152. Li, A., Li, J., Johnson, K.A., HIV-1 reverse transcriptase polymerase and RNase H (ribonuclease H) active sites work simultaneously and independently. J. Biol. Chem. 291 (2016), 26566–26585.
153. Lin, J.H., Levin, H.L., A complex structure in the mRNA of Tf1 is recognized and cleaved to generate the primer of reverse transcription. Genes Dev. 11 (1997), 270–285.
154. Linial, M.L., Eastman, S.W., Particle assembly and genome packaging. Curr. Top. Microbiol. Immunol. 277 (2003), 89–110.
155. London, R.E., Structural maturation of HIV-1 reverse transcriptase − a metamorphic solution to genomic instability. Viruses, 8, 2016, 260.
156. Lu, G., Lomonosova, E., Cheng, X., Moran, E.A., Meyers, M.J., Le Grice, S.F., Thomas, C.J., Jiang, J.K., Meck, C., Hirsch, D.R., D'Erasmo, M.P., Suyabatmaz, D.M., Murelli, R.P., Tavis, J.E., Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity. Antimicrob. Agents Chemother. 59 (2015), 1070–1079.
157. Lucifora, J., Zoulim, F., The life cycle of hepatitis B virus and antiviral targets. Future Virol. 6 (2011), 599–614.
158. Magnuson, B., Bedi, K., Ljungman, M., Genome stability versus transcript diversity. DNA Repair (Amst.) 44 (2016), 81–86.
159. Mak, J., Kleiman, L., Primer tRNAs for reverse transcription. J. Virol. 71 (1997), 8087–8095.
160. Malik, H.S., Henikoff, S., Eickbush, T.H., Poised for contagion: evolutionary origins of the infectious abilities of invertebrate retroviruses. Genome Res. 10 (2000), 1307–1318.
161. Mansky, L.M., The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virology 222 (1996), 391–400.
162. Mansky, L.M., Le Rouzic, E., Benichou, S., Gajary, L.C., Influence of reverse transcriptase variants drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. J. Virol. 77 (2003), 2071–2080.
163. Marquet, R., Isel, C., Ehresmann, C., Ehresmann, B., tRNAs as primer of reverse transcriptases. Biochimie 77 (1995), 113–124.
164. Mas, A., Vázquez-Álvarez, B.M., Domingo, E., Menéndez-Arias, L., Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors. J. Mol. Biol. 323 (2002), 181–197.
165. Masuda, T., Sato, Y., Huang, Y.L., Koi, S., Takahata, T., Hasegawa, A., Kawai, G., Kannagi, M., Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA. Sci. Rep., 5, 2015, 17680.
166. Matamoros, T., Kim, B., Menéndez-Arias, L., Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis. J. Mol. Biol. 375 (2008), 1234–1248.
167. Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F., Kunkel, T.A., Low fidelity DNA synthesis by human DNA polymerase-η. Nature 404 (2000), 1011–1013.
168. McCulloch, S.D., Kunkel, T.A., The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18 (2008), 148–161.
169. 2+-induced conformational switch rendering a competent DNA polymerase catalytic complex. Proteins 71 (2008), 565–574.
170. Menéndez-Arias, L., Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases. Progr. Nucleic Acid Res. Mol. Biol. 71 (2002), 91–147.
171. Menéndez-Arias, L., Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Virus Res. 134 (2008), 124–146.
172. Menéndez-Arias, L., Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses 1 (2009), 1137–1165.
173. Menéndez-Arias, L., Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments. Antiviral Res. 98 (2013), 93–120.
174. Menéndez-Arias, L., HIV reverse transcriptase fidelity, clade diversity, and acquisition of drug resistance. Le Grice, S.F.J., Götte, M., (eds.) Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success, 2013, Springer Science + Business Media, New York, 225–252.
175. Menéndez-Arias, L., Betancor, G., Matamoros, T., HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors. Antiviral Res. 92 (2011), 139–149.
176. Menéndez-Arias, L., Álvarez, M., Pacheco, B., Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance. Curr. Opin. Virol. 8 (2014), 1–9.
177. Meyer, P.R., Matsuura, S.E., Mian, A.M., So, A.G., Scott, W.A., A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell. 4 (1999), 35–43.
178. Michailidis, E., Kirby, K.A., Hachiya, A., Yoo, W., Hong, S.P., Kim, S.O., Folk, W.R., Sarafianos, S.G., Antiviral therapies: focus on hepatitis B reverse transcriptase. Int. J. Biochem. Cell Biol. 44 (2012), 1060–1071.
179. Michailidis, E., Huber, A.D., Ryan, E.M., Ong, Y.T., Leslie, M.D., Matzek, K.B., Singh, K., Marchand, B., Hagedorn, A.N., Kirby, K.A., Rohan, L.C., Kodama, E.N., Mitsuya, H., Parniak, M.A., Sarafianos, S.G., 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanisms. J. Biol. Chem. 289 (2014), 24533–24548.
180. Misra, H.S., Pandey, P.K., Pandey, V.N., An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer. J. Biol. Chem. 273 (1998), 9785–9789.
181. Mitchell, M.S., Tözsér, J., Princler, G., Lloyd, P.A., Auth, A., Derse, D., Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase. J. Biol. Chem. 281 (2006), 3964–3971.
182. Molina, J.M., Cahn, P., Grinsztejn, B., Lazzarin, A., Mills, A., Saag, M., Supparatpinyo, K., Walmsley, S., Crauwels, H., Rimsky, L.T., Vanveggel, S., Boven, K., ECHO study group, Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet 378 (2011), 238–246.
183. Moore, M.D., Fu, W., Nikolaitchik, O., Chen, J., Ptak, R.G., Hu, W.S., Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J. Virol. 81 (2007), 4002–4011.
184. Nair, G.R., Dash, C., Le Grice, S.F., DeStefano, J.J., Viral reverse transcriptases show selective high affinity binding to DNA–DNA primer-templates that resemble the polypurine tract. PLoS One, 7, 2012, e41712.
185. Nassal, M., Hepatitis B viruses: reverse transcription a different way. Virus Res. 134 (2008), 235–249.
186. Nassal, M., HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64 (2015), 1972–1984.
187. Ndongwe, T.P., Adedeji, A.O., Michailidis, E., Ong, Y.T., Hachiya, A., Marchand, B., Ryan, E.M., Rai, D.K., Kirby, K.A., Whatley, A.S., Burke, D.H., Johnson, M., Ding, S., Zheng, Y.M., Liu, S.L., Kodama, E., Delviks-Frankenberry, K.A., Pathak, V.K., Mitsuya, H., Parniak, M.A., Singh, K., Sarafianos, S.G., Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase. Nucleic Acids Res. 40 (2012), 345–359.
188. Nikolenko, G.N., Palmer, S., Maldarelli, F., Mellors, J.W., Coffin, J.M., Pathak, V.K., Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 2093–2098.
189. Ninio, J., Transient mutators: a semiquantitative analysis of the influence of translation and transcription errors on mutation rates. Genetics 129 (1991), 957–962.
190. Nowak, E., Potrzebowski, W., Konarev, P.V., Rausch, J.W., Bona, M.K., Svergun, D.I., Bujnicki, J.M., Le Grice, S.F., Nowotny, M., Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid. Nucleic Acids Res. 41 (2013), 3874–3887.
191. Nowak, E., Miller, J.T., Bona, M.K., Studnicka, J., Szczepanowski, R.H., Jurkowski, J., Le Grice, S.F., Nowotny, M., Ty3 reverse transcriptase complexed with an RNA-DNA hybrid shows structural and functional asymmetry. Nat. Struct. Mol. Biol. 21 (2014), 389–396.
192. O'Neil, P.K., Sun, G., Yu, H., Ron, Y., Dougherty, J.P., Preston, B.D., Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J. Biol. Chem. 277 (2002), 38053–38061.
193. Ohrui, H., 2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity. Chem. Rec. 6 (2006), 133–143.
194. Olivares, I., Mulky, A., Boross, P.I., Tözsér, J., Kappes, J.C., López-Galíndez, C., Menéndez-Arias, L., HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions. J. Mol. Biol. 372 (2007), 369–381.
195. Onafuwa, A., An, W., Robson, N.D., Telesnitsky, A., Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J. Virol. 77 (2003), 4577–4587.
196. Onafuwa-Nuga, A., Telesnitsky, A., The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol. Mol. Biol. Rev. 73 (2009), 451–480.
197. Operario, D.J., Reynolds, H.M., Kim, B., Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases. Virology 335 (2005), 106–121.
198. Oz-Gleenberg, I., Herschhorn, A., Hizi, A., Reverse transcriptases can clamp together nucleic acids strands with two complementary bases at their 3'-termini for initiating DNA synthesis. Nucleic Acids Res. 39 (2011), 1042–1053.
199. Oz-Gleenberg, I., Herzig, E., Hizi, A., Template-independent DNA synthesis activity associated with the reverse transcriptase of the long terminal repeat retrotransposon Tf1. FEBS J. 279 (2012), 142–153.
200. Panganiban, A.T., Fiore, D., Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 241 (1988), 1064–1069.
201. Paulson, B.A., Zhang, M., Schultz, S.J., Champoux, J.J., Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo. Virology 366 (2007), 361–376.
202. Perach, M., Hizi, A., Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria. Virology 259 (1999), 176–189.
203. Perrino, F.W., Preston, B.D., Sandell, L.L., Loeb, L.A., Extension of mismatched 3′ termini of DNA is a major determinant of the infidelity of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 8343–8347.
204. Piekna-Przybylska, D., Sharma, G., Bambara, R.A., Mechanism of HIV-1 RNA dimerization in the central region of the genome and significance for viral evolution. J. Biol. Chem. 288 (2013), 24140–24150.
205. Poch, O., Sauvaget, I., Delarue, M., Tordo, N., Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8 (1989), 3867–3874.
206. Pullen, K.A., Ishimoto, L.K., Champoux, J.J., Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 66 (1992), 367–373.
207. Pullen, K.A., Rattray, A.J., Champoux, J.J., The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 268 (1993), 6221–6227.
208. Pult, I., Abbott, N., Zhang, Y.Y., Summers, J., Frequency of spontaneous mutations in an avian hepadnavirus infection. J. Virol. 75 (2001), 9623–9632.
209. Rausch, J.W., Bona-Le Grice, M.K., Henrietta, M., Nymark-McMahon, H., Miller, J.T., Le Grice, S.F., Interaction of p55 reverse transcriptase from the Saccharomyces cerevisiae retrotransposon Ty3 with conformationally distinct nucleic acid duplexes. J. Biol. Chem. 275 (2000), 13879–13887.
210. Ray, A.S., Fordyce, M.W., Hitchcock, M.J., Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of human immunodeficiency virus. Antiviral Res. 125 (2016), 63–70.
211. Rein, A., Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biol. 7 (2010), 700–705.
212. Ren, J., Stammers, D.K., Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Virus Res. 134 (2008), 157–170.
213. Ren, J., Bird, L.E., Chamberlain, P.P., Stewart-Jones, G.B., Stuart, D.I., Stammers, D.K., Structure of HIV-2 reverse transcriptase at 2.35-Å resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 14410–14415.
214. Rethwilm, A., The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 277 (2003), 1–26.
215. Rethwilm, A., Molecular biology of foamy viruses. Med. Microbiol. Immunol. 199 (2010), 197–207.
216. Rezende, L.F., Drosopoulos, W.C., Prasad, V.R., The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Res. 26 (1998), 3066–3072.
217. Rhee, S.Y., Blanco, J.L., Jordan, M.R., Taylor, J., Lemey, P., Varghese, V., Hamers, R.L., Bertagnolio, S., Rinke de Wit, T.F., Aghokeng, A.F., Albert, J., Avi, R., Avila-Rios, S., Bessong, P.O., Brooks, J.I., Boucher, C.A., Brumme, Z.L., Busch, M.P., Bussmann, H., Chaix, M.L., Chin, B.S., D'Aquin, T.T., De Gascun, C.F., Derache, A., Descamps, D., Deshpande, A.K., Djoko, C.F., Eshleman, S.H., Fleury, H., Frange, P., Fujisaki, S., Harrigan, P.R., Hattori, J., Holguin, A., Hunt, G.M., Ichimura, H., Kaleebu, P., Katzenstein, D., Kiertiburanakul, S., Kim, J.H., Kim, S.S., Li, Y., Lutsar, I., Morris, L., Ndembi, N., Ng, K.P., Paranjape, R.S., Peeters, M., Poljak, M., Price, M.A., Ragonnet-Cronin, M.L., Reyes-Terán, G., Rolland, M., Sirivichayakul, S., Smith, D.M., Soares, M.A., Soriano, V.V., Ssemwanga, D., Stanojevic, M., Stefani, M.A., Sugiura, W., Sungkanuparph, S., Tanuri, A., Tee, K.K., Truong, H.M., van de Vijver, D.A., Vidal, N., Yang, C., Yang, R., Yebra, G., Ioannidis, J.P., Vandamme, A.M., Shafer, R.W., Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. PLoS Med., 12, 2015, e1001810 Erratum in: PLoS Med. 12, 2015, e1001845.
218. Rhodes, T., Wargo, H., Hu, W.S., High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J. Virol. 77 (2003), 11193–11200.
219. Rhodes, T.D., Nikolaitchik, O., Chen, J., Powell, D., Hu, W.S., Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J. Virol. 79 (2005), 1666–1677.
220. Roberts, J.D., Bebenek, K., Kunkel, T.A., The accuracy of reverse transcriptase from HIV-1. Science 242 (1988), 1171–1173.
221. Roberts, J.D., Preston, B.D., Johnston, L.A., Soni, A., Loeb, L.A., Kunkel, T.A., Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol. Cell. Biol. 9 (1989), 469–476.
222. Roth, M.J., Tanese, N., Goff, S.P., Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J. Biol. Chem. 260 (1985), 9326–9335.
223. Rothnie, H.M., Chapdelaine, Y., Hohn, T., Pararetroviruses and retroviruses: a comparative review of viral structure and gene expression strategies. Adv. Virus Res. 44 (1994), 1–67.
224. Salie, Z.L., Kirby, K.A., Michailidis, E., Marchand, B., Singh, K., Rohan, L.C., Kodama, E.N., Mitsuya, H., Parniak, M.A., Sarafianos, S.G., Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA). Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 9274–9279.
225. Sarafianos, S.G., Das, K., Clark, A.D., Jr., Ding, J., Boyer, P.L., Hughes, S.H., Arnold, E., Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 10027–10032.
226. Sarafianos, S.G., Das, K., Tantillo, C., Clark, A.D. Jr., Ding, Whitcomb, J.M., Boyer, P.L., Hughes, S.H., Arnold, E., Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (2001), 1449–1461.
227. Sarafianos, S.G., Clark, A.D. Jr., Das, K., Tuske, S., Birktoft, J.J., Ilankumaran, P., Ramesha, A.R., Sayer, J.M., Jerina, D.M., Boyer, P.L., Hughes, S.H., Arnold, E., Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J. 21 (2002), 6614–6624.
228. Sarafianos, S.G., Marchand, B., Das, K., Himmel, D.M., Parniak, M.A., Hughes, S.H., Arnold, E., Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J. Mol. Biol. 385 (2009), 693–713.
229. Schlub, T.E., Smyth, R.P., Grimm, A.J., Mak, J., Davenport, M.P., Accurately measuring recombination between closely related HIV-1 genomes. PLoS Comput. Biol., 6, 2010, e1000766.
230. Schlub, T.E., Grimm, A.J., Smyth, R.P., Cromer, D., Chopra, A., Mallal, S., Venturi, V., Waugh, C., Mak, J., Davenport, M.P., Fifteen to twenty percent of HIV substitution mutations are associated with recombination. J. Virol. 88 (2014), 3837–3849.
231. Schneider, A., Peter, D., Schmitt, J., Leo, B., Richter, F., Rösch, P., Wöhrl, B.M., Hartl, M.J., Structural requirements for enzymatic activities of foamy virus protease-reverse transcriptase. Proteins 82 (2014), 375–385.
232. Shah, F.S., Curr, K.A., Hamburgh, M.E., Parniak, M., Mitsuya, H., Arnez, J.G., Prasad, V.R., Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 275 (2000), 27037–27044.
233. Sharaf, N.G., Poliner, E., Slack, R.L., Christen, M.T., Byeon, I.J., Parniak, M.A., Gronenborn, A.M., Ishima, R., The p66 immature precursor of HIV-1 reverse transcriptase. Proteins 82 (2014), 2343–2352.
234. Simon-Loriere, E., Galetto, R., Hamoudi, M., Archer, J., Lefeuvre, P., Martin, D.P., Robertson, D.L., Negroni, M., Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog., 5, 2009, e1000418.
235. Simon-Loriere, E., Rossolillo, P., Negroni, M., RNA structures, genomic organization and selection of recombinant HIV. RNA Biol. 8 (2011), 280–286.
236. Smith, J.S., Roth, M.J., Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3). J. Biol. Chem. 267 (1992), 15071–15079.
237. Smith, S.J., Pauly, G.T., Akram, A., Melody, K., Ambrose, Z., Schneider, J.P., Hughes, S.H., Rilpivirine and doravirine have complementary efficacies against NNRTI-resistant HIV-1 mutants. J. Acquir. Immune Defic. Syndr. 72 (2016), 485–491.
238. Smyth, R.P., Davenport, M.P., Mak, J., The origin of genetic diversity in HIV-1. Virus Res. 169 (2012), 415–429.
239. Smyth, R.P., Schlub, T.E., Grimm, A.J., Waugh, C., Ellenberg, P., Chopra, A., Mallal, S., Cromer, D., Mak, J., Davenport, M.P., Identifying recombination hot spots in the HIV-1 genome. J. Virol. 88 (2014), 2891–2902.
240. Spannaus, R., Schneider, A., Hartl, M.J., Wöhrl, B.M., Bodem, J., Foamy virus Gag p71-p68 cleavage is required for template switch of the reverse transcriptase. J. Virol. 87 (2013), 7774–7776.
241. Stuke, A.W., Ahmad-Omar, O., Hoefer, K., Hunsmann, G., Jentsch, K.D., Mutations in the SIV env and the M13 lacZα gene generated in vitro by reverse transcriptases and DNA polymerases. Arch. Virol. 142 (1997), 1139–1154.
242. Stuyver, L.J., Locarnini, S.A., Lok, A., Richman, D.D., Carman, W.F., Dienstag, J.L., Schinazi, R.F., Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33 (2001), 751–757.
243. Swanstrom, R., Varmus, H.E., Bishop, J.M., The terminal redundancy of the retrovirus genome facilitates chain elongation by reverse transcriptase. J. Biol. Chem. 256 (1981), 1115–1121.
244. Takamatsu, Y., Tanaka, Y., Kohgo, S., Murakami, S., Singh, K., Das, D., Venzon, D.J., Amano, M., Higashi-Kuwata, N., Aoki, M., Delino, N.S., Hayashi, S., Takahashi, S., Sukenaga, Y., Haraguchi, K., Sarafianos, S.G., Maeda, K., Mitsuya, H., 4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus. Hepatology 62 (2015), 1024–1036.
245. Taube, R., Loya, S., Avidan, O., Perach, M., Hizi, A., Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization. Biochem. J. 329 (1998), 579–587.
246. Tavis, J.E., Lomonosova, E., The hepatitis B virus ribonuclease H as a drug target. Antiviral Res. 118 (2015), 132–138.
247. Tavis, J.E., Cheng, X., Hu, Y., Totten, M., Cao, F., Michailidis, E., Aurora, R., Meyers, M.J., Jacobsen, E.J., Parniak, M.A., Sarafianos, S.G., The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog., 9, 2013, e1003125.
248. Tekeste, S.S., Wilkinson, T.A., Weiner, E.M., Xu, X., Miller, J.T., Le Grice, S.F., Clubb, R.T., Chow, S.A., Interaction between reverse transcriptase and integrase is required for reverse transcription during HIV-1 replication. J. Virol. 89 (2015), 12058–12069.
249. Temin, H.M., Mizutani, S., RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226 (1970), 1211–1213.
250. Thomas, J.A., Gorelick, R.J., Nucleocapsid protein function in early infection processes. Virus Res. 134 (2008), 39–63.
251. Thomas, D.C., Voronin, Y.A., Nikolenko, G.N., Chen, J., Hu, W.S., Pathak, V.K., Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis. J. Virol. 81 (2007), 4798–4807.
252. Torruella, M., Gordon, K., Hohn, T., Cauliflower mosaic virus produces an aspartic proteinase to cleave its polyproteins. EMBO J. 8 (1989), 2819–2825.
253. Traverse, C.C., Ochman, H., Conserved rates and patterns of transcription errors across bacterial growth states and lifestyles. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 3311–3316 Erratum in: Proc. Natl. Acad. Sci. U. S. A. 113, 2016, E4257–E4258.
254. Tu, X., Das, K., Han, Q., Bauman, J.D., Clark, A.D. Jr., Hou, X., Frenkel, Y.V., Gaffney, B.L., Jones, R.A., Boyer, P.L., Hughes, S.H., Sarafianos, S.G., Arnold, E., Structural basis of HIV-1 resistance to AZT by excision. Nat. Struct. Mol. Biol. 17 (2010), 1202–1209.
255. Tuske, S., Sarafianos, S.G., Clark, A.D. Jr., Ding, J., Naeger, L.K., White, K.L., Miller, M.D., Gibbs, C.S., Boyer, P.L., Clark, P., Wang, G., Gaffney, B.L., Jones, R.A., Jerina, D.M., Hughes, S.H., Arnold, E., Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat. Struct. Mol. Biol. 11 (2004), 469–474.
256. Villa, J.A., Pike, D.P., Patel, K.B., Lomonosova, E., Lu, G., Abdulqader, R., Tavis, J.E., Purification and enzymatic characterization of the hepatitis B virus ribonuclease H: a new target for antiviral inhibitors. Antiviral Res. 132 (2016), 186–195.
257. Vörös, J., Urbanek, A., Rautureau, G.J., O'Connor, M., Fisher, H.C., Ashcroft, A.E., Ferguson, N., Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase. J. Virol. 88 (2014), 2584–2599.
258. Wainberg, M.A., Drosopoulos, W.C., Salomon, H., Hsu, M., Borkow, G., Parniak, M., Gu, Z., Song, Q., Manne, J., Islam, S., Castriota, G., Prasad, V.R., Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271 (1996), 1282–1285.
259. Wang, G.H., Seeger, C., The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71 (1992), 663–670.
260. Wang, J.C., Nickens, D.G., Lentz, T.B., Loeb, D.D., Zlotnick, A., Encapsidated hepatitis B virus reverse transcriptase is poised on an ordered RNA lattice. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 11329–11334.
261. Wang, G., Zhao, N., Berkhout, B., Das, A.T., CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Mol. Ther. 24 (2016), 522–526.
262. Wapling, J., Moore, K.L., Sonza, S., Mak, J., Tachedjian, G., Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J. Virol. 79 (2005), 10247–10257.
263. Warren, K., Warrilow, D., Meredith, L., Harrich, D., Reverse transcriptase and cellular factors: regulators of HIV-1 reverse transcription. Viruses 1 (2009), 873–894.
264. Weiss, K.K., Chen, R., Skasko, M., Reynolds, H.M., Lee, K., Bambara, R.A., Mansky, L.M., Kim, B., A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry 43 (2004), 4490–4500.
265. Whitcomb, J.M., Kumar, R., Hughes, S.H., Sequence of the circle junction of human immunodeficiency virus type 1: Implications for reverse transcription and integration. J. Virol. 64 (1990), 4903–4906.
266. Whiting, S.H., Champoux, J.J., Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase. J. Virol. 68 (1994), 4747–4758.
267. Whiting, S.H., Champoux, J.J., Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications. J. Mol. Biol. 278 (1998), 559–577.
268. Wilhelm, M., Wilhelm, F.X., Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1. Eukaryot. Cell 4 (2005), 1057–1065.
269. Wilhelm, M., Boutabout, M., Heyman, T., Wilhelm, F.X., Reverse transcription of the yeast Ty1 retrotransposon: the mode of first strand transfer is either intermolecular or intramolecular. J. Mol. Biol. 288 (1999), 505–510.
270. Wilhelm, M., Boutabout, M., Wilhelm, F.X., Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities. Biochem. J. 348 (2000), 337–342.
271. Wood, N., Bhattacharya, T., Keele, B.F., Giorgi, E., Liu, M., Gaschen, B., Daniels, M., Ferrari, G., Haynes, B.F., McMichael, A., Shaw, G.M., Hahn, B.H., Korber, B., Seoighe, C., HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog., 5, 2009, e1000414.
272. Xiong, Y., Eickbush, T.H., Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9 (1990), 3353–3362.
273. Yang, W., Summers, J., Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion. J. Virol. 72 (1998), 8710–8717.
274. 2+-ion catalysis and substrate specificity. Mol. Cell. 22 (2006), 5–13.
275. Yu, H., Goodman, M.F., Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates. J. Biol. Chem. 267 (1992), 10888–10896.
276. Yu, H., Jetzt, A.E., Ron, Y., Preston, B.D., Dougherty, J.P., The nature of human immunodeficiency virus type 1 strand transfers. J. Biol. Chem. 273 (1998), 28384–28391.
277. Zábranský, A., Andreánsky, M., Hrusková-Heidingsfeldová, O., Havlícek, V., Hunter, E., Ruml, T., Pichová, I., Three active forms of aspartic proteinase from Mason-Pfizer monkey virus. Virology 245 (1998), 250–256.
278. Zhang, W.-H., Svarovskaia, E.S., Barr, R., Pathak, V.K., Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 10090–10095.
279. Zheng, X., Pedersen, L.C., Gabel, S.A., Mueller, G.A., Cuneo, M.J., DeRose, E.F., Krahn, J.M., London, R.E., Selective unfolding of one ribonuclease H domain of HIV reverse transcriptase is linked to homodimer formation. Nucleic Acids Res. 42 (2014), 5361–5377.
280. Zheng, X., Perera, L., Mueller, G.A., DeRose, E.F., London, R.E., Asymmetric conformational maturation of HIV-1 reverse transcriptase. Elife, 4, 2015, e06359.
281. Zinnen, S., Hsieh, J.-C., Modrich, P., Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 269 (1994), 24195–24202.